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SUMMARY
Indirect evidence suggests that improved insulin sensitivity may contribute to improved lifespan 
of mice in which aging has been slowed by mutations, drugs, or dietary means, even in stocks of 
mice that do not show signs of late-life diabetes. Peripheral responses to insulin can be augmented 
by over-expression of Syntaxin 4 (Syn4), a plasma membrane localized SNARE protein. We show 
here that Syn4 transgenic (Tg) mice with high level expression of Syn4 had a significant extension 
of lifespan (33% increase in median), and showed increased peripheral insulin sensitivity, even at 
ages where controls exhibited age-related insulin resistance. Moreover, skeletal muscle GLUT4 
and islet insulin granule exocytosis processes were fully protected in Syn4 Tg mice challenged 
with a high-fat diet. Hence, high-level expressing Syn4 Tg mice may exert better glycemic 
control, which slows multiple aspects of aging and extends lifespan, even in non-diabetic mice.
INTRODUCTION
The prevalence of type 2 diabetes mellitus (T2D) increases substantially with age. Both 
aging and T2D are accompanied by deleterious physiological changes, such as the 
development of insulin resistance, diminished glucose tolerance, fat accumulation and loss 
of muscle mass (Biddinger and Kahn, 2006; Saltiel and Kahn, 2001). Despite a strong 
correlation between aging and T2D, the molecular events linking aging and T2D are 
unknown.
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There are many mouse models in which slow aging and long life are associated with higher 
insulin sensitivity. This includes GHRKO, Snell and Ames dwarf, calorie restriction and the 
crowded litter mice (Sadagurski et al., 2014). Further, the GHRKO and pituitary dwarf 
mutations slow many aspects of aging. This has led to a model in which excellent, and 
preserved, insulin sensitivity is postulated as a key causal factor (Bartke et al., 2003) in 
extended longevity in many kinds of experimental mice. Fat-specific deletion of insulin 
receptor (IR) also leads to longevity in mice, as does deletion of IR or IRS in some brain 
regions (Bluher et al., 2003; Taguchi et al., 2007). This, too, hints at links between insulin 
sensitivity and whole animal aging.
One clue from studies of centenarians demonstrates that this population displays increased 
peripheral insulin sensitivity and reduced circulating insulin concentrations, and has reduced 
adipose tissue mass when compared to younger generations (Barbieri et al., 2003; Biddinger 
and Kahn, 2006; Kloting and Bluher, 2005; Paolisso et al., 1996; Rozing et al., 2010; 
Wijsman et al., 2011), suggesting that insulin signaling and/or synthesis genes may link 
diabetes and aging. Moreover, people with a mutation in GHR were protected against cancer 
and diabetes (Guevara-Aguirre et al., 2011). Several proteins thought to play a role in 
regulation of aging, including IGF-1 (insulin like growth factor), mTOR (mammalian target 
of rapamycin) and SIRT1 (mammalian homolog of the Silent information regulator 2), have 
also been implicated in the control of glucose homeostasis and diabetes pathogenesis. In 
humans, genetic variation causing reduced insulin/IGF-1 signaling is associated with 
extended longevity (van Heemst et al., 2005). Similarly, IGF-1 receptor deficient knockout 
mice as well as a model of reduced local IGF activity (pregnancy-associated plasma protein-
A knockout mice) show increased longevity (Conover et al., 2008; Xu et al., 2014). 
Depletion of S6K1 (a downstream target protein of mTOR) in mice increased lifespan and 
maintained insulin sensitivity (Selman et al., 2009; Um et al., 2004). SIRT1 overexpression 
in brain-specific transgenic mice was recently shown to increase lifespan by ~11% (Satoh et 
al., 2013). However, while increased SIRT1 selectively in pancreatic β cells of transgenic 
mice enhanced glucose stimulated insulin secretion and improved glucose tolerance at 8 
months of age, these benefits were lost by 18 months of age (Moynihan et al., 2005; Ramsey 
et al., 2008). Reduced insulin sensitivity has also, in some circumstances, been associated 
with lifespan extension in mice, including that mediated by rapamycin (Harper et al., 2005; 
Miller et al., 2014). Hence, whether improved insulin secretion and/or increased insulin 
sensitivity are sufficient to promote extended lifespan, remains in question.
Syn4 is a SNARE protein that functions at the distal end of the insulin signaling cascade to 
promote clearance of excess glucose from the blood. Syn4 is similarly required for 
pancreatic β cell insulin secretion in response to elevated blood glucose. Therefore, changes 
in Syn4 protein levels affect two of the most important processes required to regulate blood 
glucose levels and maintain glucose homeostasis. Importantly, Syn4 protein levels are 
significantly reduced in human T2D islets (Oh et al., 2014), as are Syn4 mRNA levels in 
ob/ob (Keller et al., 2008) and STZ-diabetic mice (Yechoor et al., 2002); mice deficient in 
Syn4 exhibit insulin resistance and dysfunctional insulin secretion (Spurlin et al., 2004; 
Spurlin and Thurmond, 2006; Yang et al., 2001). Thus, deficiency of Syn4 may be 
associated with an increased susceptibility of the aged or obese to develop T2D. In the 
current study, we report the existence of a relationship between Syn4 abundance, healthspan 
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and aging, pertinent to insulin-secreting and insulin-responsive cellular mechanisms 
affecting glucose homeostatic changes.
RESULTS
Relationship between Syn4 abundance and aging
Given the current queries into the relationship between longevity and glucose homeostasis, 
we investigated abundances of exocytosis proteins in pancreas lysates of differentially aged 
mice, and found Syn4 to be selectively attenuated in a manner inversely related to that of the 
known aging-induced p-mTOR (Fig. 1A). No differences in pancreatic abundances of Syn4-
based SNARE partners VAMP2, SNAP23 or Munc18c were observed with aging (Fig. S1). 
This observation led to a longitudinal study of Syn4 transgenic (Syn4 Tg) mice. The Syn4 
Tg mice express higher levels of Syn4 protein specifically in the pancreas, skeletal muscle 
and adipose tissues, and exhibit enhanced insulin sensitivity, accelerated glucose clearance 
(Spurlin et al., 2004) and have the capacity to release ~30% more insulin per islet while 
retaining biphasic kinetics (Spurlin and Thurmond, 2006). Remarkably, the Syn4 Tg mice 
lived ~33% longer than wild type control (Con) littermates (p<0.001), with similar effects in 
male and female mice (Fig. 1B–D). In this regard, significant up-regulation of Syn4 yields 
lifespan extension similar to that produced by caloric restriction, and more than rapamycin 
or acarbose treatments (Harrison et al., 2014; Miller et al., 2014). The overall lifespan of the 
control (Con) mice was somewhat shorter than expected for this strain of mice (Ikeno et al., 
2005). Aging-related gene products such as SIRT1 or mTOR were unchanged in pancreata 
of Syn4 Tg mice relative to littermate controls (Fig. 1E), despite the continued expression of 
the transgene in the aged Tg mice (Fig. 1F; 2.1-fold more Syn4 protein compared with Con, 
n=4). While the amount of phosphorylated FoxO1 (Ser256) was also unchanged in Syn4 Tg 
pancreata, total FoxO1 levels were 2-fold greater, thus decreasing the relative level of 
phosphorylated FoxO1 (Fig. 1E). Given the trend for reduced Syn4 protein in aged Con 
mouse muscle (Fig. S2), and the persistence of elevated Syn4 levels in the muscle of the 
aged Tg mice, (Fig. 1F; 3.3-fold more Syn4 protein compared with Con, n=4), we used 
microarray to assess potential relative changes in skeletal muscle genes. In those genes with 
absolute fold change ≥ 1.2, Ingenuity pathway analysis revealed 12 pathways that were 
significantly changed (Table S1). Pathways identified included AMPK signaling, leptin 
signaling, cAMP and nNOS signaling in skeletal muscle. Quantitative real time PCR was 
used to confirm a set of 7 differentially expressed genes from these pathways; of these, 4 
were statistically significant (Table S2). These data collectively suggested the existence of a 
specific inverse relationship between aging and Syn4 abundance.
Glucose homeostatic mechanisms in long-lived Syn4 Tg mice
Comparing the insulin tolerance tests of 25 month old mice with the response of this strain 
at 4–6 months of age (Spurlin et al., 2004), the Syn4 Tg mice showed enhanced insulin 
sensitivity (Fig. 2A). Increased insulin sensitivity was particularly notable in Syn4 Tg males 
(Fig. 2B) since aged C57BL/6 males are characteristically insulin resistant (Lee et al., 2010). 
Consistent with this, aged Syn4 Tg mice were significantly more glucose tolerant than 
controls (Fig. 2C–D). Syn4 upregulation was not associated with dwarfism and occurred 
independent of caloric restriction as evidenced by body weight and food intake measures 
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(Fig. 2E–F). Metabolic caging studies showed no significant differences between 12 month 
old Con and Tg mice for respiratory quotient (RQ) and movement/activity level (Fig. 2G–
H). Although body fat content was also similar (Fig. 2I), serum triglycerides were slightly 
but significantly diminished in the Syn4 Tg mice (Fig. 2J). These data suggest that 
increasing the capacity for exocytosis in skeletal muscle is sufficient to protect against age-
induced insulin resistance, and by extrapolation, it could be speculated that an age-generated 
deficiency in exocytosis might underlie the development of insulin resistance with aging.
Glucose tolerance and homeostasis is substantially affected by functional β cell mass. Serum 
insulin content in fasted Syn4 Tg versus Con mice was reduced at 18 months of age (Fig. 
3A), rising in both strains by age 24 months (P=0.0275 by two-way ANOVA). Following a 
glucose injection, 6 month old Syn4 Tg mice exhibited a left-shifted insulin response in 
vivo, showing a peak in serum insulin content by 5 min, as opposed to that seen in control 
mice (Fig. 3B); serum glucagon levels were not different between Syn4 Tg and Con mice 
under fasted or glucose-stimulated conditions (Fig. 3C). The rapid serum insulin response of 
the Syn4 Tg mice is consistent with an amplified glucose-stimulated insulin secretory 
response from their islets ex vivo (Fig. 3D), and was not affiliated with changes in islet 
insulin content or distribution of β and α cells within the islets (Fig. 3E–F). The percentage 
of β cell area remained similar between 18 month old Syn4 Tg and Con mice (Fig. 3G), 
although both were elevated by ~ 2-fold relative to that reported for 6 month old Syn4 Tg 
and Con littermate mice (Oh et al., 2014). These data suggest that islet function was 
increased in the Syn4 Tg mice, independent of insulin content and islet morphometry.
Syn4-induced resistance to obesity-induced dysfunction
The onset of pre/type 2 diabetes with aging is associated with increasing adiposity/obesity in 
humans. Activities of proteins associated with lifespan and longevity, such as FoxO3, 
FoxO1, mTOR, IRS1, AMPK, and SIRT1 reportedly change with high fat diet (HFD) 
(Battiprolu et al., 2012; Chalkiadaki and Guarente, 2012; Rivas et al., 2009). To assess 
whether Syn4 Tg and Con mice differ in responses to dietary fat, mice were fed a 
diabetogenic 60% HFD or regular chow diet (RD) for 10 weeks. Both Syn4 Tg and Con 
mice showed equivalently increased body weight on either RD or HFD (Fig. 4A). The 
relative fat pad weights of HFD-fed Tg and Con mice were similarly elevated above that of 
RD-fed mice (0.022 g/g BW for RD-Con and 0.024 RD–Tg, n=4/group) (Fig. 4B). Weights 
of other tissues, including liver, were similar between HFD-fed Tg and Con mice (Fig. 4B). 
This is consistent with similarities in hepatic glucose uptake function and insulin action in 
Syn4 Tg and Con mice in hyperinsulinemic-euglycemic clamp analyses (Spurlin et al., 
2004). Food intake was similar between Con and Tg mice on either RD or HFD (Fig. 4C). 
Despite the obesity, HFD-fed Syn4 Tg mice retained the normal 2-fold increase in insulin-
stimulated GLUT4 accumulation in skeletal muscle t-tubules/sarcolemma reported for 
similarly aged chow-fed control mice (dashed line)(Spurlin et al., 2004); by contrast, HFD-
fed Con mice failed to respond to insulin (Fig. 4D).
Within just 2 weeks on the HFD, fasting serum insulin levels of the Syn4 Tg mice were 
significantly higher than those of HFD-fed Con mice (Fig. 4E), elevated relative to those 
reported for similarly aged chow-fed mice (Spurlin et al., 2004). Islets from HFD-fed Syn4 
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Tg mice also retained the 16-fold increase in glucose-stimulated insulin secretion seen in the 
RD-Con mice (dashed line), while the response of the Con-HFD islets ex vivo fell by 50% 
(Fig. 4F). In terms of islet insulin content, HFD-fed Syn4 Tg mice showed an increase 
relative to RD-fed Tg mice, whereas HFD-Con and RD-Con showed no differences (Fig. 
4G). β cell area was similar between the HFD-Con and HFD-Syn4 Tg mice (Fig. 4H), with 
both being increased by nearly 2-fold relative to age-matched RD-fed mice (RD-Con and 
RD-Tg, both 0.7% in (Oh et al., 2014)), and rising to levels otherwise seen in the aged mice 
of Fig. 3G. These data suggest that Syn4 enrichment preserves exocytotic activities in 
skeletal muscle and islet β cells with aging and with obesity.
DISCUSSION
To the best of our knowledge, this is the first report of an exocytosis factor promoting 
extension of lifespan. Insight into how Syn4 promotes healthspan stems from data showing 
that Syn4 Tg mice exhibit accelerated and enhanced capacity for glucose uptake and insulin 
release, as well as faster ‘re-equilibration’ of glycemia and insulinemia following a glucose 
challenge. When challenged with HFD-induced obesity, skeletal muscle GLUT4 and islet 
insulin granule exocytosis processes were fully protected in the Syn4 Tg mice, matching 
levels equivalent to those of chow-fed Con mice; HFD-Con mice showed significant lapses 
in both exocytotic processes. Intriguingly, the Migration inhibition factor knockout mouse 
(MIF KO) showed a 15% extension of lifespan (Harper et al., 2010), and MIF deficiency is 
linked to protection from age-related insulin resistance (Verschuren et al., 2009) and from 
inflammation in islets associated with type 1 and type 2 diabetes (Stojanovic et al., 2012; 
Stosic-Grujicic et al., 2008). Despite the similarities with MIF deficiency in terms of 
lifespan extension and improvements in insulin secretion and insulin action, the Syn4-
enriched Tg mice did not exhibit differences in inflammation, as assessed via serum levels 
of inflammatory factors TNFα or IL-6, with aging or under HFD-induced inflammatory 
conditions (Tables S3–S4). However, finding that the capacity of islets of HFD-fed Syn4 Tg 
mice to increase insulin content, without increasing β cell mass, suggests that this exocytotic 
protein may play an otherwise unappreciated role in insulin biosynthesis. The increased 
capacity to synthesize and secrete insulin may be unrelated to the increased lifespan of the 
Syn4 Tg mouse however, since the long-lived GHRKO mouse has marked reductions in 
these aspects (Bartke and Westbrook, 2012; Coschigano et al., 2003; Junnila et al., 2013; 
List et al., 2011).
Microarray analysis of muscle from Syn4 Tg and Con mice pointed to changes in pathways 
of leptin and AMPK signaling, as well as cAMP and nNOS signaling in skeletal muscle, and 
components of these pathways are affiliated with lifespan extension (Tables S1–S2). At the 
protein level, relative phosphorylated FoxO1 in pancreata from the Syn4 Tg mice was 
reduced, consistent with the association of health and longevity with decreased pFoxO1 in 
liver (Laurent et al., 2008; Tomobe et al., 2013). Relatedly, pFoxO1 is elevated in cardiac 
tissue of diabetic and HFD-fed mice (Battiprolu et al., 2012). Our findings of ‘normal’ 
insulin sensitivity in aged Syn4 Tg mice provides a clue suggestive of increased ‘healthspan’ 
in addition to longevity, although more evidence will be required to demonstrate broad 
improvement in late-life health in these mice. Preservation of insulin sensitivity into old age 
may reflect enhanced responsiveness by the skeletal muscle to the insulin signal, itself a 
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consequence of more rapid GLUT4 vesicle accumulation at the t-tubule/sarcolemmal 
membranes, leading to faster clearance of circulating glucose. This is consistent with reports 
citing hyperglycemia as damaging to cells and leading to shorter lifespan (Fitzenberger et 
al., 2013; Yang et al., 2005). Additionally, this enhanced muscle response to insulin was 
maintained in obese Syn4 Tg mice. The decreased serum triglyceride content of the aged 
Syn4 Tg mice was unexpected, particularly given that 3–6 month old Syn4 Tg mice or HFD-
fed Syn4 Tg mice failed to show differences from paired Con mice in triglyceride contents 
(Spurlin et al., 2004). While Syn4 Tg mice at 3–4 months of age also show normal hepatic 
insulin signaling and glucose uptake, and normal adipocyte glucose uptake and glycolytic 
functions (Spurlin et al., 2004), it remains possible that crosstalk from the tissues expressing 
the transgene in this model (pancreas, skeletal muscle and fat) to the liver, or functions 
directly in the fat, affect serum triglyceride levels with increasing age.
Syn4 may also act through changes in NAD metabolism in one or more of these tissues 
expressing the transgene. Increased NAD is associated with increased healthspan and 
longevity [reviewed in (Verdin, 2014)],dependent upon SIRT1 (Mitchell et al., 2014), and 
NAD-mediated PARP inhibition in C. elegans (Mouchiroud et al., 2013). However, SIRT1 
protein and transcript levels of all sirtuins detected were normal, and although PARP could 
not be detected in the islet by microarray methods, it is their activity that NAD influences 
acutely, and hence may be impacted somehow by increased Syn4. Another possibility is that 
Syn4 indirectly impacts IR function in aging via its ability to bind and potentially chaperone 
translation of the IR substrate protein, Munc18c (Jewell et al., 2011; Spurlin et al., 2004; 
Yang et al., 2001), and that this alters IR signaling in aging at a post-transcriptional level to 
extend lifespan. The current report is also accompanied by a second site replicate cohort 
conducted at the University of Michigan, which revealed potential ‘site effects’ and 
transgene dosage effects upon lifespan (Thurmond et al, 2015). Hence, efforts to sort out the 
potential roles for Syn4 in aging will require tissue-specific Syn4 transgenic models to 
clarify the individual tissue-related beneficial contributions to the longevity phenotype. For 
example, would a β cell specific Syn4 transgenic mouse show improved peripheral insulin 
sensitivity? Indeed, reports from other models suggest that improved β cell function could be 
sufficient to control peripheral insulin resistance (Buchanan et al., 2002; Li et al., 2004). 
Alternatively, a skeletal muscle-specific Syn4 mouse protected from age-induced insulin 
resistance could obviate the need for compensatory elevation of β cell insulin release. 
Examination of such models may otherwise reveal that it is the simultaneous enrichment of 
Syn4 in the β cell and skeletal muscle that confers the extended healthspan and longevity 
phenotype, which would be important going forward with strategies to target Syn4 
expression and activation.
EXPERIMENTAL PROCEDURES
Animals
All animal studies were approved by the Indiana University School of Medicine Institutional 
Animal Care and Use Committee (IACUC). The rat Syntaxin 4 cDNA inserted into the 
pUC-Combi targeting vector (Schultze et al., 1996) was used to generate heterozygous 
transgenic mice on the C57BL/6J strain background as described (Spurlin et al., 2004); 
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wildtype littermates served as controls. Detailed methods are available in Supplemental 
Materials.
Metabolic Studies
Mice were fasted for IPGTT (2 g glucose/kg BW) and ITT (0.75 U/kg BW) studies, as 
described (Spurlin et al., 2004). Indirect calorimetric measurement was performed using a 
TSE systems LabMaster Metabolism Research Platform (Chesterfield, MO). Body fat 
percentage was measured by DEXA. Serum analytes were quantified by the Hormone Assay 
and Analytical Services Core at Vanderbilt University (Nashville, TN).
GLUT4 Translocation
Fasted male mice were injected intraperitoneally with 21 U/kg BW Humulin or vehicle 
(saline) and sacrificed for removal of the hindquarter muscles for homogenization and 
subsequent differential centrifugation and detection of GLUT4 as described (Zhou et al., 
1998).
Islet Isolation and Immunofluorescence, and Tissue Immunohistochemistry and 
Immunoblotting
Mouse islets were isolated as described (Spurlin et al., 2004). Islet morphometry was used to 
determine β cell area as described (Wang et al., 2011); data shown represent 3 sections per 
pancreata, using 3 pancreata from each group. Pancreatic and skeletal muscle hindlimb 
lysate proteins were resolved for immunoblot detection as described (Oh et al., 2014).
Microarray
Hindlimb skeletal muscle was dissected from 5 month old Con and Syn4 Tg mice for RNA 
isolation. RNA was labeled using the Ambion WT expression kit and hybridized to 
Affymetrix Mouse Gene 1.0 ST arrays. Differentially expressed genes were analyzed using 
the 2014 Fall Release of QIAGEN’s Ingenuity® Pathway Analysis (IPA®, QIAGEN 
Redwood City, www.qiagen.com/ingenuity). Pathway, Functional and Upstream analysis 
were performed using Genes which had absolute fold changes ≥ 1.2. Data for the 
microarrays are deposited in NCBI’s GEO with series accession number GSE63780.
Statistical Analysis
All values are presented as means ± SE. Differences were analyzed by Student’s t test or 
two-way ANOVA.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Syntaxin 4 abundance is inversely related to aging.
• Aged Syntaxin 4 enriched mice retain youthful glucose and insulin tolerances
• Syntaxin 4 enrichment protects from high-fat induced muscle and islet 
derangements
Oh et al. Page 12
Cell Metab. Author manuscript; available in PMC 2016 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 1. Syn4 abundance and aging
(A) Protein levels in pancreata of 4 and 18 months old C57BL/6J mice: Syn4 relative to 
tubulin (loading control), phosphorylated mTOR relative to total mTOR. Data represent the 
mean ± S.E. of 5 sets of pancreata. *P<0.05. (B–D) Proportion of all mice surviving, for 
males (12 Con and 11 Syn4 Tg), females (7 Con and 6 Syn4 Tg) versus both sexes pooled 
(19 Con and 17 Syn4 Tg). (E) Abundance/activation of proteins associated with aging in 3 
paired sets of pancreata from male mice: phosphorylated/total mTOR, total SIRT1 and 
phosphorylated/total FoxO1 (pSer256). (F) Levels of transgene expression in aged male 
pancreatic and skeletal muscle (Sk. Muscle) mouse lysates, representative of n=4/group).
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Fig. 2. Improved insulin and glucose tolerance in aged Syn4 Tg mice
Insulin tolerance tests were assessed in 25 month old mice with both sexes combined (A), or 
males alone (B); *P<0.05 (A, 8 Con and 12 Tg mice; B, 6 Con and 8 Tg mice). Glucose 
tolerance tests were performed in 24 month old mice, both with sexes combined (C), and in 
males alone (D) with bar graphs denoting area under the curve (AUC); *P<0.05 (C, 12 Con 
and 16 Tg; D, 8 Con and 9 Tg mice). Metabolic caging studies, wherein data represent the 
average ± S.E. for 4–9 pairs of 12 month old male and female mice: body weights (E), food 
intake (F), respiratory quotient (G), and physical activity (H). DEXA scanning quantified 
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body fat in 4 pairs of 8 month old male mice (I). Serum triglycerides (18 month old 7 Con 
and 7 Tg, sexes combined) (J); *p<0.05. BW, body weight.
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Fig. 3. Syn4 Tg mice show robust islet function
(A) Fasting serum insulin content in aged mice. Data represent the average ± S.E. (18 
months: 7 Con, 6 Tg mice; 24 months: 5 Con and 5 Tg). (B–C) Serum insulin and glucagon 
contents during glucose tolerance testing in 6 month old male mice. Data represent the 
average ± S.E. of 6–8 mice per group; *p<0.05 versus Con at same time point. Glucagon in 
serum from mice fasted (0) and after glucose stimulation (10 min). (D–E) Static insulin 
release from mouse islets ex vivo, and insulin content therefrom (n=3–4 islet batches from 6 
month old mice); *p<0.05. (F–G) Islet cell distributions (red, glucagon stained α cell; green, 
insulin stained β cell) and percentage of β cell area in 18 month old mouse islets (n=3/
group).
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Fig. 4. Protection of skeletal muscle and islet function in high-fat fed Syn4 Tg male mice
Body weight (A), tissue weights (B), and food intake (C) in control (Con) and Syn4 Tg mice 
(panels A and C, n=8–12 per group; panel B, n=4–5 per group). (D) Skeletal muscle GLUT4 
accumulated at the cell surface (stimulation index=insulin/basal levels of GLUT4 at cell 
surface). Data represent the average ± S.E. of 4 matched sets of mice/group; *p<0.05). 
Dashed line, average RD-Con mice. (E) Fasting serum insulin content during the HFD study 
(n=6 mice/group; *p<0.05). (F) Glucose stimulated insulin release (stimulation 
index=glucose stimulated/basal) of islets from mice fed HFD for 10 weeks (n=3 mice/
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group). Dashed line, average RD-Con mice; p=0.07, RD-Con versus HFD-Con. (G) Islet 
insulin content after 10 weeks on HFD; data represent the average ± S.E. of 6 mice/group; 
*p<0.05 versus Tg fed the RD. (H) β cell area for 6 month old mice fed HFD for 10 wks; 
n=3 pancreata/group. Body weight (BW).
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